A randomized, placebo controlled, parallel-group, multicenter clinical trial to evaluate the preventive effect on acute exacerbation of chronic obstructive pulmonary disease (COPD) with Carbocisteine (1500mg/day)

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2006
INTERVENTION: Carbocisteine group 1500mg/day (13 months) Placebo group (13 months) CONDITION: COPD PRIMARY OUTCOME: Frequency of exacerbations INCLUSION CRITERIA: 1. Stable COPD patient (Stage II‐IV) 2. Between 40 and 80 years 3. Out‐patient 4. Written informed consent 5. At least 2 exacerbations in the previous 2 years
Epistemonikos ID: 2ab127768723e8747dbb5b65eb0fd2d0b8762d90
First added on: Aug 21, 2024